Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Mate Co., Ltd.

Japan

Certifications
GMP PMDA JAPAN
Services
    Licensing & Distribution Finished Formulation Manufacturer & Supplier

Company Overview

Mate Co., Ltd. is a licensed pharmaceutical wholesaler based in Osaka, Japan (Wholesale License No. B14309, Osaka Prefectural Government, valid through February 2028). We specialize in the export of Japanese finished dosage pharmaceutical products to international markets. Our product range includes prescription medicines across therapeutic areas including anti-inflammatory, oncology, ophthalmology, and antifungal categories. All products are sourced through authorized Japanese distribution channels, ensuring authenticity, traceability, and compliance with Japanese Pharmacopoeia (JP) standards. We offer FOB Kansai International Airport (KIX) shipping with 100% T/T advance payment terms.

Downloadable Documents
Company Information
Address: 2-10-30 Nonomiya, Ibaraki City, Osaka 567-0862, Japan
Established: 2017
Nature of Business: Pharmaceutical Wholesaler & Exporter
Turnover:
No. of Employees:
LinkedIn:

Frequently asked questions

Mate Co., Ltd. operates as a pharmaceutical wholesaler & exporter based in Japan. Full product specifications are available on the company profile.

Mate Co., Ltd. holds the following certifications on its PharmaTradz profile: GMP, PMDA JAPAN. Certificates are verified at onboarding and copies can be requested with your enquiry.

Use the enquiry button on this profile or send an RFP with your product, strength, destination market and quantity. Your requirement reaches the supplier and the PharmaTradz BD team, and a structured quote is returned to you.

Suppliers listed on PharmaTradz export across Asia, Africa, Latin America, MENA, the EU and CIS markets. Share your destination market in your enquiry to confirm registration status, documentation and export capability for your country. Controlled substances are supplied strictly against valid import and export permits.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.